Underwood Capital Limited has released a press release.
MMJ to Commence Phase 2 Clinical Trial on Pediatric Epilepsy
Filed with ASX ·
6ix hasn’t read this filing yet.
Underwood Capital Limited on 6ix
Story so far
Earlier from Underwood Capital
- MMJ Enters Strategic Land Package Agreement
- Canada Takes Steps Towards Recreational Legalisation
- Health Canada Grants MMJ License to Produce Medical Cannabis
- MMJ Marks AUS Market Entry with Two Strategic Partnerships
- Progress on MMJs Lucky Lake Facility MMPR Application
Later from Underwood Capital
- MMJ Core Cannabis Brands to List on TSX-V via RTO
- MMJ Raises $4 Million in an Over-Subscribed Share Placement
- MMJ Receives Superior Offer To List Core Assets on TSX-V
- United Greeneries Receives Cannabis Seed Import Permit
- MMJ Signs Definitive Agreement with Harvest One
Follow Underwood Capital into a list and get an email when it puts out news.
Follow Underwood Capital